Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology

• Κύριοι συγγραφείς: Feng Xu (Συγγραφέας), Mei Zhang (Συγγραφέας), Hongmei Wu (Συγγραφέας), Yuanmin Wang (Συγγραφέας), Ye Yang (Συγγραφέας), Xiangpei Wang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Context Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action.Objective Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes.Materials...